APA (7th ed.) Citation

Alsaleh, K., Al Zahwahry, H., Bounedjar, A., Oukkal, M., Saadeddine, A., Mahfouf, H., . . . Ayari, J. (2023). Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: A phase III randomized double-blind SAFIA trial. Journal of Cancer Research & Clinical Oncology, 149(9), 6171. https://doi.org/10.1007/s00432-023-04588-3

Chicago Style (17th ed.) Citation

Alsaleh, K., et al. "Neoadjuvant Endocrine Therapy with or Without Palbociclib in Low-risk Patients: A Phase III Randomized Double-blind SAFIA Trial." Journal of Cancer Research & Clinical Oncology 149, no. 9 (2023): 6171. https://doi.org/10.1007/s00432-023-04588-3.

MLA (9th ed.) Citation

Alsaleh, K., et al. "Neoadjuvant Endocrine Therapy with or Without Palbociclib in Low-risk Patients: A Phase III Randomized Double-blind SAFIA Trial." Journal of Cancer Research & Clinical Oncology, vol. 149, no. 9, 2023, p. 6171, https://doi.org/10.1007/s00432-023-04588-3.